These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy. Hradilova N; Sadilkova L; Palata O; Mysikova D; Mrazkova H; Lischke R; Spisek R; Adkins I PLoS One; 2017; 12(2):e0171539. PubMed ID: 28187172 [TBL] [Abstract][Full Text] [Related]
10. Maximizing dendritic cell migration in cancer immunotherapy. Verdijk P; Aarntzen EH; Punt CJ; de Vries IJ; Figdor CG Expert Opin Biol Ther; 2008 Jul; 8(7):865-74. PubMed ID: 18549318 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy. Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625 [TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Homma S; Sagawa Y; Ito M; Ohno T; Toda G Clin Exp Immunol; 2006 Apr; 144(1):41-7. PubMed ID: 16542363 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccine and cancer treatment: new patents. Aleixo AA; Michelin MA; Murta EF Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):26-9. PubMed ID: 24397783 [TBL] [Abstract][Full Text] [Related]
15. Cell fusion: from hybridoma to dendritic cell-based vaccine. Gong J; Koido S; Calderwood SK Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954 [TBL] [Abstract][Full Text] [Related]
16. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy. Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105 [TBL] [Abstract][Full Text] [Related]
17. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240 [TBL] [Abstract][Full Text] [Related]
18. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape. Garg AD; Coulie PG; Van den Eynde BJ; Agostinis P Trends Immunol; 2017 Aug; 38(8):577-593. PubMed ID: 28610825 [TBL] [Abstract][Full Text] [Related]
20. Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Versteven M; Van den Bergh JMJ; Marcq E; Smits ELJ; Van Tendeloo VFI; Hobo W; Lion E Front Immunol; 2018; 9():394. PubMed ID: 29599770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]